Q4 2025 Earnings Call February 23, 2026 2:00 AM ESTCompany ParticipantsPeter Duffy - CEO & DirectorNiall McBride - CFO ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...
Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics ...
Quick lube sees a growth opportunity for preventative maintenance amid a buoyant market for M&A; many suppliers ...
The USD 480 school board continued to hear High Reliability Schools (HRS updates) at its most recent meeting Monday evening, this time from Bright Start Early Learning Center (BSELC). BSELC Principal ...
ECONOMYNEXT – Revenue collected by Sri Lanka Customs in the first 19 days of February 2026 has accounted for over 96 percent of the month’s target, official data showed.
Sri Lanka's central bank will re-visit its inflation target as part of renewing an agreement with the government, Director of Economic Research S Jegajeevan said amid calls to reduce the high target ...
Moving on to everyday matters: the polls are continuing and will run until the end of the week. I believe that from this wave of surveys, Mitsotakis emerges as a winner, and I think Tsipras as well, ...
JPMorgan CEO Jamie Dimon said AI has already displaced workers at the bank and outlined the redeployment strategy HR leaders ...
Zymeworks to receive $250 million under a royalty-backed note financing from Royalty Pharma with repayments due from 30% of worldwide tiered royalties on Ziihera until fully repaidZymeworks to retain ...
As writers for a web site largely focused on human artistic endeavors and cultural criticism of the same, we here at The A.V. Club are, at least in a general sense, well-disposed toward artists. (Even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results